Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Floyd

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Bulletin of the World Health Organization|June 27, 2006
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from IndiaKatherine Floyd, V K Arora, K J R Murthy, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 18, 2014
Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance dataMatteo Zignol, Masoud Dara, Anna S Dean, et al.
BMJ Global Health|April 3, 2018
Priorities for global political momentum to end TB: a critical point in timeTereza Kasaeva, Annabel Baddeley, Katherine Floyd, et al.
Bulletin of the World Health Organization|August 13, 2011
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortalityPhilippe Glaziou, Katherine Floyd, Eline L Korenromp, et al.
The European Respiratory Journal|February 25, 2012
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and RussiaKatherine Floyd, Raymond Hutubessy, Kai Kliiman, et al.
The European Respiratory Journal|September 28, 2014
Multidrug-resistant tuberculosis around the world: what progress has been made?Dennis Falzon, Fuad Mirzayev, Fraser Wares, et al.
Plos Pathogens|May 15, 2020
Toxoplasma gondii requires its plant-like heme biosynthesis pathway for infectionAmy Bergmann, Katherine Floyd, Melanie Key, et al.
The Lancet. Global Health|March 28, 2018
The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1Daniel J Carter, Philippe Glaziou, Knut Lönnroth, et al.
The European Respiratory Journal|August 20, 2021
World Health Organization treatment outcome definitions for tuberculosis: 2021 updateNguyen Nhat Linh, Kerri Viney, Medea Gegia, et al.
Emerging Themes in Epidemiology|October 1, 2013
Analysis of tuberculosis prevalence surveys: new guidance on best-practice methodsSian Floyd, Charalambos Sismanidis, Norio Yamada, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Bulletin of the World Health Organization|June 27, 2006
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from IndiaKatherine Floyd, V K Arora, K J R Murthy, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 18, 2014
Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance dataMatteo Zignol, Masoud Dara, Anna S Dean, et al.
BMJ Global Health|April 3, 2018
Priorities for global political momentum to end TB: a critical point in timeTereza Kasaeva, Annabel Baddeley, Katherine Floyd, et al.
Bulletin of the World Health Organization|August 13, 2011
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortalityPhilippe Glaziou, Katherine Floyd, Eline L Korenromp, et al.
The European Respiratory Journal|February 25, 2012
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and RussiaKatherine Floyd, Raymond Hutubessy, Kai Kliiman, et al.
The European Respiratory Journal|September 28, 2014
Multidrug-resistant tuberculosis around the world: what progress has been made?Dennis Falzon, Fuad Mirzayev, Fraser Wares, et al.
Plos Pathogens|May 15, 2020
Toxoplasma gondii requires its plant-like heme biosynthesis pathway for infectionAmy Bergmann, Katherine Floyd, Melanie Key, et al.
The Lancet. Global Health|March 28, 2018
The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1Daniel J Carter, Philippe Glaziou, Knut Lönnroth, et al.
The European Respiratory Journal|August 20, 2021
World Health Organization treatment outcome definitions for tuberculosis: 2021 updateNguyen Nhat Linh, Kerri Viney, Medea Gegia, et al.
Emerging Themes in Epidemiology|October 1, 2013
Analysis of tuberculosis prevalence surveys: new guidance on best-practice methodsSian Floyd, Charalambos Sismanidis, Norio Yamada, et al.
Pageof 8